Health
As variants threaten Covid-19 progress, US weighs trial results of Johnson & Johnson vaccine candidate – CNN International
As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight,…
(CNN)As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight, despite trial reports showing apparently lower efficacy rates than two vaccines already authorized in the US.
Johnson & Johnson’s single-shot coronavirus vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial and 85% effective against severe disease, the company announced Friday. It…
-
General16 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General24 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
General7 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay